Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEVOLUTION: Neoadjuvant Nivolumab in Upper Tract Urothelial Carcinoma
NCT05160285Phase 2Unknown
- Start
- Dec 2020
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in upper tract urothelial carcinoma (UTUC). Status: unknown.
02
Drugs
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT05160285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160285.